EUS is superior for detection of pancreatic lesions compared with standard imaging in patients with multiple endocrine neoplasia type 1

Article ID	Journal	Published Year	Pages	File Type
3302584	Gastrointestinal Endoscopy	2015	11 Pages	PDF

Abstract

EUS is superior to CT/MRIÂ + SRS for pancreatic lesion detection in patients with MEN1. In thisÂ setting, 11C-5-HTP PET is not useful. We recommend EUS as the first-choice pancreas imaging technique in patients with MEN1. (Clinical trial registration number: NTR1668.)

Keywords

SRS 18F-DOPA MEN1 PNET MRI Magnetic resonance imaging Pancreatic neuroendocrine tumor Neuroendocrine tumor Positron emission tomography NET Somatostatin receptor scintigraphy PET multiple endocrine neoplasia type 1

Related Topics

Health Sciences Medicine and Dentistry Gastroenterology

Preview

EUS is superior for detection of pancreatic lesions compared with standard imaging in patients with multiple endocrine neoplasia type 1

Authors

Sophie J. MD, PhD, Adrienne H. MD, PhD, Hendrik M. MD, PhD, Eric J. MD, PhD, Alfons H.H. MD, Ido P. PhD, Klaas P. MD, PhD, Gerlof D. MD, PhD, Henri J. MD, PhD, Wouter W. MD, PhD, Richard A. MD, PhD, Paul MD, PhD, Wim J. PhD, Elisabeth G.E. MD, PhD,